The August issue of Vascular Disease Management features useful information for vascular specialists on endovascular aneurysm repair, current studies on peripheral vascular disease, and original research on PAD’s effect on STEMI.
Editor in chief Frank Criado, MD, FACS, FSVM, also gives pointers on how to conduct a successful debate at clinical meetings.
Access the August table of contents below.
Volume 10 – Issue 8 – August 2013
Editor’s Corner »
A successful medical debate is one that both informs and entertains its viewers.
Case Files by Dr. George »
Totally Percutaneous Endovascular Aneurysm Repair of Abdominal Aortic Aneurysm with a 14 Fr Low-Profile Stent Graft
Although open surgical repair was previously the treatment of choice, endovascular aneurysm repair has recently become the preferred modality for abdominal aortic aneurysm when feasible.
Original Research »
The Comorbidity of Peripheral Arterial Disease Attenuates Complications During Primary Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction
The authors retrospectively studied 75 patients to determine if a history of peripheral arterial disease attenuates complications during primary percutaneous coronary intervention in patents with acute ST-elevation myocardial infarction.
Endovascular Techniques »
Retrograde recanalization via fluoroscopic or ultrasound-guided puncture of reconstituted pedal vessels may allow lesion traversal in difficult cases, allowing primary retrograde revascularization or rendezvous techniques with subsequent antegrade intervention.
Editorial Commentary »
EVAR continues to evolve, and moving forward the appeal of percutaneous EVAR, with availability of lower profile and highly flexible systems and the expanding capability to achieve successful endovascular repair of juxtarenal and pararenal aneurysms, will grow.
Vascular Disease Management spoke with Michael Murphy, MD, from the Indiana University Department of Surgery, about the MarrowStim therapy and details of the trial.
Vascular Disease Management interviewed Hence Verhagen, MD, who presented data on a subset analysis of efficacy of the Endurant AAA Stent Graft System at the Charing Cross meeting in London.